Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.


OBJECTIVE To report our 3-year experience with the use of once-daily intraperitoneal (IP) gentamicin in the treatment of gram-negative continuous ambulatory peritoneal dialysis (CAPD) peritonitis. DESIGN A prospective cohort study in prevalent CAPD patients. SETTING A tertiary care institution. PATIENTS All CAPD patients who presented with new… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics